
focus
aratana pet therapeut
therapeut dog cat
belgium aratana portfolio pipelin
includ small molecul biolog
target medic condit dog cat
requir disclosur end report
petx entyc disappoint gallipr demonstr
stock floor reiter buy pt
view current cl king meet event calendar coverag univers
aratana post okay base strong gallipr osteoarthr
pain sale although nocita post-operative pain dog entcy
inappet lack appetit cat lag think although
remain cautiou risk profil aratana see revenu ramp
full challeng think three drug current market
achiev gallipr mileston payment potenti
nr takeout de-risk stori reiter buy rate rais
price target
call quarter rel mix overal valu compani
driven aratana strateg valu compani quiet
call around strateg altern believ recent bloomberg-report
newsflash aratana activ look bidder like compani
cautiou around commun investor ultim
valu petx driven elanco abil convinc parent
nr sharehold lilli own good
number non-mileston revenu beat street product
revenu estim driven gallipr licens revenu
ep beat estim base mileston payment
nocita nocita post revenu vs
estim think drug acceler earn due launch
entyc sold mani clinic although see
nocita smaller market could high penetr rate
entyc entyc post revenu also miss
estim aratana believ clinic order
drug custom reorder entyc ultim
determin valu compani right annual revenu could
well like figur next quarter
aratana note file order target account increas
sequenti everi quarter better proxi what happen
end-market rather revenu subject distributor fill
gallipr gallipr licens revenu crush
estim drug main focu elanco gallipr
revenueup almost sequenti think order time
due introduct dose gener believ gallipr
model rais revenu ep estim lower
revenu ep project respect new revenu
ep estim versu
previous base stronger-than-expect gallipr sale
respect revis revenu ep forecast vs prior
estim vs previous base slower-
than-expect entyc sale revenu ep estim go
respect
valuat petx price target use multipl
revenu estim although acknowledg lower
estim increas fair valu think strateg interest effect
put floor stock
risk achiev price target
commit fundrais
time mileston payment
page
